The 15th International Oncolytic Virotherapy Conference: Clinical successes point to a brighter future for cancer treatment
The 15th International Oncolytic Virotherapy Conference took place in Banff, Alberta, and showcased diverse new approaches to enhancing oncolytic virus therapy. A reflective keynote highlighted industry challenges and lessons. Presentations covered preclinical advancements, combination therapies, me...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-03-01
|
| Series: | Molecular Therapy: Oncology |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S295032992400016X |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850162563084451840 |
|---|---|
| author | Jahanara Rajwani Danyel Evseev Esha S. Kaul Douglas J. Mahoney |
| author_facet | Jahanara Rajwani Danyel Evseev Esha S. Kaul Douglas J. Mahoney |
| author_sort | Jahanara Rajwani |
| collection | DOAJ |
| description | The 15th International Oncolytic Virotherapy Conference took place in Banff, Alberta, and showcased diverse new approaches to enhancing oncolytic virus therapy. A reflective keynote highlighted industry challenges and lessons. Presentations covered preclinical advancements, combination therapies, mechanisms and biomarkers, and many examples of clinical efficacy against various cancers. |
| format | Article |
| id | doaj-art-eee9b470c1e34d8a8f545a5478c068ca |
| institution | OA Journals |
| issn | 2950-3299 |
| language | English |
| publishDate | 2024-03-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Molecular Therapy: Oncology |
| spelling | doaj-art-eee9b470c1e34d8a8f545a5478c068ca2025-08-20T02:22:32ZengElsevierMolecular Therapy: Oncology2950-32992024-03-0132120077410.1016/j.omton.2024.200774The 15th International Oncolytic Virotherapy Conference: Clinical successes point to a brighter future for cancer treatmentJahanara Rajwani0Danyel Evseev1Esha S. Kaul2Douglas J. Mahoney3Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB T2N 4N1, Canada; Alberta Children’s Hospital Research Institute, University of Calgary, Calgary, AB T2N 4N1, Canada; Department of Biochemistry and Molecular Biology, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, CanadaArnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB T2N 4N1, Canada; Department of Microbiology, Immunology, and Infectious Diseases, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, CanadaArnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB T2N 4N1, Canada; The Calvin, Joan and Phoebe Snyder Institute for Chronic Disease, University of Calgary, Calgary, AB T2N 4N1, Canada; Department of Microbiology, Immunology, and Infectious Diseases, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, CanadaArnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB T2N 4N1, Canada; Alberta Children’s Hospital Research Institute, University of Calgary, Calgary, AB T2N 4N1, Canada; Department of Biochemistry and Molecular Biology, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada; The Calvin, Joan and Phoebe Snyder Institute for Chronic Disease, University of Calgary, Calgary, AB T2N 4N1, Canada; Department of Microbiology, Immunology, and Infectious Diseases, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada; Corresponding author: Douglas J. Mahoney, Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB T2N 4N1, Canada.The 15th International Oncolytic Virotherapy Conference took place in Banff, Alberta, and showcased diverse new approaches to enhancing oncolytic virus therapy. A reflective keynote highlighted industry challenges and lessons. Presentations covered preclinical advancements, combination therapies, mechanisms and biomarkers, and many examples of clinical efficacy against various cancers.http://www.sciencedirect.com/science/article/pii/S295032992400016X |
| spellingShingle | Jahanara Rajwani Danyel Evseev Esha S. Kaul Douglas J. Mahoney The 15th International Oncolytic Virotherapy Conference: Clinical successes point to a brighter future for cancer treatment Molecular Therapy: Oncology |
| title | The 15th International Oncolytic Virotherapy Conference: Clinical successes point to a brighter future for cancer treatment |
| title_full | The 15th International Oncolytic Virotherapy Conference: Clinical successes point to a brighter future for cancer treatment |
| title_fullStr | The 15th International Oncolytic Virotherapy Conference: Clinical successes point to a brighter future for cancer treatment |
| title_full_unstemmed | The 15th International Oncolytic Virotherapy Conference: Clinical successes point to a brighter future for cancer treatment |
| title_short | The 15th International Oncolytic Virotherapy Conference: Clinical successes point to a brighter future for cancer treatment |
| title_sort | 15th international oncolytic virotherapy conference clinical successes point to a brighter future for cancer treatment |
| url | http://www.sciencedirect.com/science/article/pii/S295032992400016X |
| work_keys_str_mv | AT jahanararajwani the15thinternationaloncolyticvirotherapyconferenceclinicalsuccessespointtoabrighterfutureforcancertreatment AT danyelevseev the15thinternationaloncolyticvirotherapyconferenceclinicalsuccessespointtoabrighterfutureforcancertreatment AT eshaskaul the15thinternationaloncolyticvirotherapyconferenceclinicalsuccessespointtoabrighterfutureforcancertreatment AT douglasjmahoney the15thinternationaloncolyticvirotherapyconferenceclinicalsuccessespointtoabrighterfutureforcancertreatment AT jahanararajwani 15thinternationaloncolyticvirotherapyconferenceclinicalsuccessespointtoabrighterfutureforcancertreatment AT danyelevseev 15thinternationaloncolyticvirotherapyconferenceclinicalsuccessespointtoabrighterfutureforcancertreatment AT eshaskaul 15thinternationaloncolyticvirotherapyconferenceclinicalsuccessespointtoabrighterfutureforcancertreatment AT douglasjmahoney 15thinternationaloncolyticvirotherapyconferenceclinicalsuccessespointtoabrighterfutureforcancertreatment |